zonisamide
Generic: zonisamide
Labeler: ncs healthcare of ky, llc dba vangard labsDrug Facts
Product Profile
Brand Name
zonisamide
Generic Name
zonisamide
Labeler
ncs healthcare of ky, llc dba vangard labs
Dosage Form
CAPSULE
Routes
Active Ingredients
zonisamide 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0615-8266
Product ID
0615-8266_994eb4b5-f6d8-442c-88a2-5fd6ec8ca762
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077869
Listing Expiration
2026-12-31
Marketing Start
2016-07-13
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
06158266
Hyphenated Format
0615-8266
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
zonisamide (source: ndc)
Generic Name
zonisamide (source: ndc)
Application Number
ANDA077869 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 30 CAPSULE in 1 BLISTER PACK (0615-8266-39)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "994eb4b5-f6d8-442c-88a2-5fd6ec8ca762", "openfda": {"nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "unii": ["459384H98V"], "rxcui": ["314285"], "spl_set_id": ["226d917a-33de-48cc-baf6-bd6a20668341"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BLISTER PACK (0615-8266-39)", "package_ndc": "0615-8266-39", "marketing_start_date": "20190110"}], "brand_name": "zonisamide", "product_id": "0615-8266_994eb4b5-f6d8-442c-88a2-5fd6ec8ca762", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "P-Glycoprotein Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "0615-8266", "generic_name": "zonisamide", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "zonisamide", "active_ingredients": [{"name": "ZONISAMIDE", "strength": "100 mg/1"}], "application_number": "ANDA077869", "marketing_category": "ANDA", "marketing_start_date": "20160713", "listing_expiration_date": "20261231"}